Synolo Therapeutics
1 known investors
Find your way into Synolo Therapeutics
Synolo Therapeutics develops conditionally-active immunotherapies for treating cancer, using a proprietary discovery platform to build a pipeline of oncology drug candidates. It aims to offer treatments that are more effective and safer than the current standard of care.
Investors · 1
Frequently asked questions
- What does Synolo Therapeutics do?
- Synolo Therapeutics develops conditionally-active immunotherapies for treating cancer, using a proprietary discovery platform to build a pipeline of oncology drug candidates. It aims to offer treatments that are more effective and safer than the current standard of care.
- Who are Synolo Therapeutics's investors?
- Synolo Therapeutics's investors include RA Capital.